4.6 Article

The Urinary Bladder Transcriptome and Proteome Defined by Transcriptomics and Antibody-Based Profiling

期刊

PLOS ONE
卷 10, 期 12, 页码 -

出版社

PUBLIC LIBRARY SCIENCE
DOI: 10.1371/journal.pone.0145301

关键词

-

资金

  1. Knut and Alice Wallenberg Foundation
  2. Stockholm County Council

向作者/读者索取更多资源

To understand functions and diseases of urinary bladder, it is important to define its molecular constituents and their roles in urinary bladder biology. Here, we performed genome-wide deep RNA sequencing analysis of human urinary bladder samples and identified genes upregulated in the urinary bladder by comparing the transcriptome data to those of all other major human tissue types. 90 protein-coding genes were elevated in the urinary bladder, either with enhanced expression uniquely in the urinary bladder or elevated expression together with at least one other tissue (group enriched). We further examined the localization of these proteins by immunohistochemistry and tissue microarrays and 20 of these 90 proteins were localized to the whole urothelium with a majority not yet described in the context of the urinary bladder. Four additional proteins were found specifically in the umbrella cells (Uroplakin 1a, 2, 3a, and 3b), and three in the intermediate/basal cells (KRT17, PCP4L1 and ATP1A4). 61 of the 90 elevated genes have not been previously described in the context of urinary bladder and the corresponding proteins are interesting targets for more in-depth studies. In summary, an integrated omics approach using transcriptomics and antibody-based profiling has been used to define a comprehensive list of proteins elevated in the urinary bladder.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Respiratory System

Plasma proteins elevated in severe asthma despite oral steroid use and unrelated to Type-2 inflammation

Maria Sparreman Mikus, Johan Kolmert, Lars Andersson, Jorgen Ostling, Richard G. Knowles, Cristina Gomez, Magnus Ericsson, John-Olof Thorngren, Payam Emami Khoonsari, Barbro Dahlen, Maciej Kupczyk, Bertrand De Meulder, Charles Auffray, Per S. Bakke, Bianca Beghe, Elisabeth H. Bel, Massimo Caruso, Pascal Chanez, Bo Chawes, Stephen J. Fowler, Mina Gaga, Thomas Geiser, Mark Gjomarkaj, Ildiko Horvath, Peter H. Howarth, Sebastian L. Johnston, Guy Joos, Norbert Krug, Paolo Montuschi, Jacek Musial, Ewa Nizankowska-Mogilnicka, Henric K. Olsson, Alberto Papi, Klaus F. Rabe, Thomas Sandstrom, Dominick E. Shaw, Nikolaos M. Siafakas, Mathias Uhlen, John H. Riley, Stewart Bates, Roelinde J. M. Middelveld, Craig E. Wheelock, Kian Fan Chung, Ian M. Adcock, Peter J. Sterk, Ratko Djukanovic, Peter Nilsson, Sven-Erik Dahlen, Anna James

Summary: This study aimed to identify plasma biomarkers associated with asthma phenotypes by analyzing the samples from two well-characterized cohorts of severe and mild-to-moderate asthmatics. The results revealed several proteins that were significantly different between severe and mild-to-moderate asthmatics, and treatment with oral corticosteroids reduced the levels of these proteins. However, differences in protein levels between severe and mild-to-moderate asthmatics remained even after correction for corticosteroid use.

EUROPEAN RESPIRATORY JOURNAL (2022)

Article Neurosciences

Longitudinal Serum Metabolomics in Extremely Premature Infants: Relationships With Gestational Age, Nutrition, and Morbidities

Anders K. Nilsson, Abdellah Tebani, Daniel Malmodin, Anders Pedersen, Gunnel Hellgren, Chatarina Lofqvist, Ingrid Hansen-Pupp, Mathias Uhlen, Ann Hellstrom

Summary: As an increasing number of extremely premature infants survive, understanding the maturation of their metabolome and its relation to the development of morbidities is crucial. This study used 1H-NMR to analyze the serum metabolic profile of 87 preterm infants and found that the metabolome of extremely premature infants changes substantially in the neonatal period, largely driven by the transition from total parenteral nutrition to full enteral feeding.

FRONTIERS IN NEUROSCIENCE (2022)

Article Chemistry, Multidisciplinary

Multiomics Analysis Reveals the Impact of Microbiota on Host Metabolism in Hepatic Steatosis

Mujdat Zeybel, Muhammad Arif, Xiangyu Li, Ozlem Altay, Mengnan Shi, Murat Akyildiz, Burcin Saglam, Mehmet Gokhan Gonenli, Buket Yigit, Burge Ulukan, Dilek Ural, Saeed Shoaie, Hasan Turkez, Jens Nielsen, Cheng Zhang, Mathias Uhlen, Jan Boren, Adil Mardinoglu, Hong Yang

Summary: This study characterized MAFLD patients using multiomics data and revealed the impact of dysbiosis in the oral and gut microbiome and host-microbiome interactions on HS. Key features of HS were identified using these data and predicted and validated in a separate cohort.

ADVANCED SCIENCE (2022)

Correction Multidisciplinary Sciences

Spatiotemporal dissection of the cell cycle with single-cell proteogenomics (Feb, 10.1038/s41586-021-03232-9, 2022)

Diana Mahdessian, Anthony J. Cesnik, Christian Gnann, Frida Danielsson, Lovisa Stenstrom, Muhammad Arif, Cheng Zhang, Trang Le, Fredric Johansson, Rutger Schutten, Anna Backstrom, Ulrika Axelsson, Peter Thul, Nathan H. Cho, Oana Carja, Mathias Uhlen, Adil Mardinoglu, Charlotte Stadler, Cecilia Lindskog, Burcu Ayoglu, Manuel D. Leonetti, Fredrik Ponten, Devin P. Sullivan, Emma Lundberg

NATURE (2022)

Article Multidisciplinary Sciences

The neuropeptide landscape of human prefrontal cortex

Wen Zhong, Swapnali Barde, Nicholas Mitsios, Csaba Adori, Per Oksvold, Kalle von Feilitzen, Liam O'Learyd, Laszlo Csiba, Tibor Hortobagyi, Peter Szocsics, Naguib Mechawar, Zsofia Magloczky, Eva Renner, Miklos Palkovits, Mathias Uhlen, Jan Mulder, Tomas Hokfelt

Summary: This study provides an overview of the distribution of peptidergic systems in the human prefrontal cortex (hPFC) and identifies unique peptide/transmitter-related profiles in different subregions of the hPFC. The results suggest the involvement of neuropeptide signaling in stabilizing circuit connectivity and modulating hPFC functions during health and disease.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2022)

Article Medicine, Research & Experimental

Combined metabolic activators improve metabolic functions in the animal models of neurodegenerative diseases

Hasan Turkez, Ozlem Altay, Serkan Yildirim, Xiangyu Li, Hong Yang, Cemil Bayram, Ismail Bolat, Sena Oner, Ozlem Ozdemir Tozlu, Mehmet Enes Arslan, Muhammad Arif, Burak Yulug, Lutfu Hanoglu, Seyda Cankaya, Simon Lam, Halil Aziz Velioglu, Ebru Coskun, Ezgi Idil, Rahim Nogaylar, Ahmet Ozsimsek, Ahmet Hacimuftuoglu, Saeed Shoaie, Cheng Zhang, Jens Nielsen, Jan Boren, Mathias Uhlen, Adil Mardinoglu

Summary: The study indicates that neurodegenerative diseases are associated with metabolic abnormalities. The administration of combined metabolic activators (CMA) improves metabolic disorders in animal models of Alzheimer's disease (AD) and Parkinson's disease (PD). CMA treatment shows promising results in improving neurological and metabolic parameters in NDDs.

LIFE SCIENCES (2023)

Article Biotechnology & Applied Microbiology

Discovery of drug-omics associations in type 2 diabetes with generative deep-learning models

Rosa Lundbye Allesoe, Agnete Troen Lundgaard, Ricardo Hernandez Medina, Alejandro Aguayo-Orozco, Joachim Johansen, Jakob Nybo Nissen, Caroline Brorsson, Gianluca Mazzoni, Lili Niu, Jorge Hernansanz Biel, Valentas Brasas, Henry Webel, Michael Eriksen Benros, Anders Gorm Pedersen, Piotr Jaroslaw Chmura, Ulrik Plesner Jacobsen, Andrea Mari, Robert Koivula, Anubha Mahajan, Ana Vinuela, Juan Fernandez Tajes, Sapna Sharma, Mark Haid, Mun-Gwan Hong, Petra B. Musholt, Federico De Masi, Josef Vogt, Helle Krogh Pedersen, Valborg Gudmundsdottir, Angus Jones, Gwen Kennedy, Jimmy Bell, E. Louise Thomas, Gary Frost, Henrik Thomsen, Elizaveta Hansen, Tue Haldor Hansen, Henrik Vestergaard, Mirthe Muilwijk, Marieke T. Blom, Leen M. T. Hart, Francois Pattou, Violeta Raverdy, Soren Brage, Tarja Kokkola, Alison Heggie, Donna McEvoy, Miranda Mourby, Jane Kaye, Andrew Hattersley, Timothy McDonald, Martin Ridderstrale, Mark Walker, Ian Forgie, Giuseppe N. Giordano, Imre Pavo, Hartmut Ruetten, Oluf Pedersen, Torben Hansen, Emmanouil Dermitzakis, Paul W. Franks, Jochen M. Schwenk, Jerzy Adamski, Mark McCarthy, Ewan Pearson, Karina Banasik, Simon Rasmussen, Soren Brunak

Summary: The application of multiple omics technologies in biomedical cohorts can reveal patient-level disease characteristics and individualized response to treatment. We developed a deep-learning-based framework, MOVE, to integrate and analyze multi-omics data from a cohort of newly diagnosed type 2 diabetes patients. By using in silico perturbations, we identified drug-omics associations in the multi-modal datasets with higher sensitivity than univariate statistical tests.

NATURE BIOTECHNOLOGY (2023)

Article Nutrition & Dietetics

Ellagic Acid and Its Metabolites as Potent and Selective Allosteric Inhibitors of Liver Pyruvate Kinase

Umberto Maria Battisti, Chunixa Gao, Fady Akladios, Woonghee Kim, Hong Yang, Cemil Bayram, Ismail Bolat, Metin Kiliclioglu, Nursena Yuksel, Ozlem Ozdemir Tozlu, Cheng Zhang, Jihad Sebhaoui, Shazia Iqbal, Saeed Shoaie, Ahmet Hacimuftuoglu, Serkan Yildirim, Hasan Turkez, Mathias Uhlen, Jan Boren, Adil Mardinoglu, Morten Grotli

Summary: This study presents a new finding that ellagic acid and its derivatives can selectively and potently inhibit liver pyruvate kinase, which may open up new therapeutic options for non-alcoholic fatty liver disease (NAFLD).

NUTRIENTS (2023)

Article Neurosciences

Combined metabolic activators improve cognitive functions in Alzheimer's disease patients: a randomised, double-blinded, placebo-controlled phase-II trial

Burak Yulug, Ozlem Altay, Xiangyu Li, Lutfu Hanoglu, Seyda Cankaya, Simon Lam, Halil Aziz Velioglu, Hong Yang, Ebru Coskun, Ezgi Idil, Rahim Nogaylar, Ahmet Ozsimsek, Cemil Bayram, Ismail Bolat, Sena Oner, Ozlem Ozdemir Tozlu, Mehmet Enes Arslan, Ahmet Hacimuftuoglu, Serkan Yildirim, Muhammad Arif, Saeed Shoaie, Cheng Zhang, Jens Nielsen, Hasan Turkez, Jan Boren, Mathias Uhlen, Adil Mardinoglu

Summary: A clinical trial was conducted to study the effect of combined metabolic activators (CMA) on Alzheimer's disease (AD) patients. The results showed that CMA can improve cognitive functions and clinical parameters associated with AD. This study provides evidence for the use of CMA in the treatment of AD.

TRANSLATIONAL NEURODEGENERATION (2023)

Article Mathematical & Computational Biology

Metabolic modelling of the human gut microbiome in type 2 diabetes patients in response to metformin treatment

Bouchra Ezzamouri, Dorines Rosario, Gholamreza Bidkhori, Sunjae Lee, Mathias Uhlen, Saeed Shoaie

Summary: The human gut microbiome plays a significant role in metabolic disorders, such as type 2 diabetes mellitus. This study investigates the mechanistic role of the gut microbiome in response to metformin treatment, using metagenomics data and genome-scale metabolic modeling. The results demonstrate the commensal and competing behavior of key bacterial species in response to metformin and highlight the impact of different nutritional environments.

NPJ SYSTEMS BIOLOGY AND APPLICATIONS (2023)

Article Multidisciplinary Sciences

Targeted proteomics using stable isotope labeled protein fragments enables precise and robust determination of total apolipoprotein(a) in human plasma

Andreas Hober, Mirela Rekanovic, Bjorn Forsstrom, Sara Hansson, David Kotol, Andrew J. Percy, Mathias Uhlen, Jan Oscarsson, Fredrik Edfors, Tasso Miliotis

Summary: This study presents a novel quantitative approach to determine the absolute concentration of apo(a) in two microliters of plasma using proteotypic peptides, which meets the requirements for targeted proteomics assays. The assay parameters were optimized, and the LC-SRM/MS results were compared with a commercially available immunoassay.

PLOS ONE (2023)

Article Multidisciplinary Sciences

Multiplexed selectivity screening of anti-GPCR antibodies

Leo Dahl, Ilana B. Kotliar, Annika Bendes, Tea Dodig-Crnkovic, Samuel Fromm, Arne Elofsson, Mathias Uhlen, Thomas P. Sakmar, Jochen M. Schwenk

Summary: A multiplexed immunoassay was developed to test the selectivity of over 400 anti-GPCR antibodies. The results showed that about 61% of the antibodies were selective, 11% bound off-target, and 28% did not bind to any GPCR. It was also found that on-target antibodies had longer, more disordered antigens and were less buried in the interior of GPCR proteins compared to other antibodies.

SCIENCE ADVANCES (2023)

Editorial Material Endocrinology & Metabolism

Revisiting the role of serine metabolism in hepatic lipogenesis

Hong Yang, Cheng Zhang, Hasan Turkez, Mathias Uhlen, Jan Boren, Adil Mardinoglu

NATURE METABOLISM (2023)

Review Biotechnology & Applied Microbiology

Sequential sequencing by synthesis and the next-generation sequencing revolution

Mathias Uhlen, Stephen R. Quake

Summary: The impact of next-generation sequencing (NGS) is of great significance in the field of life science, contributing to our understanding of human health, disease, biology, and ecology. The majority of NGS systems are based on the concept of 'sequencing by synthesis' (SBS), which uses engineered DNA polymerase for sequential detection of nucleotide incorporation. This review discusses some key concepts leading to the development of NGS technology.

TRENDS IN BIOTECHNOLOGY (2023)

Article Oncology

Absolute Quantification of Pan-Cancer Plasma Proteomes Reveals Unique Signature in Multiple Myeloma

David Kotol, Jakob Woessmann, Andreas Hober, Maria Bueno Alvez, Khue Hua Tran Minh, Fredrik Ponten, Linn Fagerberg, Mathias Uhlen, Fredrik Edfors

Summary: This study utilized mass spectrometry to study proteins in the blood samples of cancer patients and identified potential markers for diagnosing multiple myeloma. By using machine learning and differential expression analysis, a high-accuracy diagnostic model was established, which has significant implications for diagnostic tools in cancer research.

CANCERS (2023)

暂无数据